Back

The prognostic utility of the 1-min STST for long-term adverse outcomes in patients with pulmonary hypertension

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Pulmonary atrial hypertension: prognosis Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Christina Kronberger

Medical University of Vienna, Vienna (Austria)

6 More presentations in this session

Presentation thumbnail
Discussant - Pulmonary atrial hypertension: prognosis
Presentation thumbnail
Prognostic value of changes in electrocardiographic abnormalities in patients with pulmonary arterial hypertension.
Doctor W. Hinojosa Camargo (Avila, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic value of plasma gamma-butyrobetaine traits in pulmonary hypertension: a large cohort study has now been assessed
Ms W. Yan (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) questionnaire scores predict mortality and hospitalizations in patients with pulmonary hypertension
Doctor M. Grzeda (Manchester, GB)
Abstract
Presentation thumbnail
Evaluating the prognostic role of the albumin-bilirubin and albumin-bilirubin-platelet scores in patients with pulmonary arterial hypertension
Professor C. Kaymaz (Istanbul, TR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Pulmonary atrial hypertension: prognosis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The optimal cut-off value for the one-minute sit-to-stand test to determine functional impairment in patients with pulmonary hypertension
thumbnail
Congress Presentation
In patients with chronic heart failure pulmonary artery enlargement is related to low functional capacity assessed with the one-minute sit-to-stand test
thumbnail
Congress Presentation
Long-term survival outcomes and baseline hemodynamics in patients with PAH versus CTEPH

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources